Tapewire

Nasdaq · USD

VISN

Vistance Networks, Inc.

Export transactions ↓
Tapewire entity
4717
SEC CIK
0001517228
Parsed reports
477

Last 12 months

Inside the activity.

1 purchase rows · 2 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202600
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202611
Sep 202601
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
May 08, 2017 Filed May 10, 2017 20:25 UTC PurchaseCommon Stock 3,000 $35.34 $106,031.10
Disclosure

SEC source: 0001209191-17-031261 · doc4.xml · nonDerivative · entry 1

Yates Timothy T · CIK 0001354697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,067

F1 · balance_after: As previously reported, includes 4,470 restricted stock units granted on May 5, 2017 pursuant to the issuer's non-employee director compensation plan, which will vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:27 UTC GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030945 · doc4.xml · nonDerivative · entry 1

KRAUSE L WILLIAM · CIK 0001055438 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,064

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:21 UTC GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030936 · doc4.xml · nonDerivative · entry 1

GRAY STEPHEN C · CIK 0001140860 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,064

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 16:16 UTC GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030924 · doc4.xml · nonDerivative · entry 1

ADAMS AUSTIN A · CIK 0001195339 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,146

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:33 UTC
Manning TomDirector
GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030951 · doc4.xml · nonDerivative · entry 1

Manning Tom · CIK 0001343053 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,306

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vests on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:30 UTC GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030947 · doc4.xml · nonDerivative · entry 1

Maguire Joanne M · CIK 0001368472 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,309

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vests on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:38 UTC GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030961 · doc4.xml · nonDerivative · entry 1

Yates Timothy T · CIK 0001354697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 28,067

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vest on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 05, 2017 Filed May 9, 2017 20:35 UTC GrantCommon Stock 4,470 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-030955 · doc4.xml · nonDerivative · entry 1

Watts Claudius E. IV · CIK 0001408738 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,623

F1 · acquired: Reflects restricted stock units granted pursuant to the issuer's non-employee director compensation plan, which vests on May 5, 2018, subject to the director's continued membership on the Board of Directors on such date.

F2 · balance_after: As previously reported, includes 1,153 restricted stock units granted on January 23, 2017 pursuant to the issuer's non-employee director compensation plan, which will vest on January 23, 2018, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
May 01, 2017 Filed May 2, 2017 09:26 UTC SaleCommon Stock 15,000 $42.18 $632,712.00
Disclosure

SEC source: 0001209191-17-029067 · doc4.xml · nonDerivative · entry 1

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,284,744

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.

F2 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $41.98 to $42.29. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
April 11, 2017 Filed Apr 12, 2017 16:28 UTC
WYATT FRANK B IISVP, General Counsel & Sec
Exercise / conversionCommon Stock (Right to Buy) · Derivative 130,356 $0.00 Strike: $5.74 $0.00
Disclosure

SEC source: 0001209191-17-026687 · doc4.xml · derivative · entry 6

WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 130,356 shares

Expires 2021-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017.

Read SEC document
April 11, 2017 Filed Apr 12, 2017 16:28 UTC
WYATT FRANK B IISVP, General Counsel & Sec
SaleCommon Stock 130,356 $40.58 $5,289,533.63
Disclosure

SEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 4

WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,675

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017.

F4 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.25 to $40.74. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
April 11, 2017 Filed Apr 12, 2017 16:28 UTC
WYATT FRANK B IISVP, General Counsel & Sec
Exercise / conversionCommon Stock 130,356 $5.74 $748,243.44
Disclosure

SEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 3

WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 195,031

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017.

F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
April 10, 2017 Filed Apr 12, 2017 16:28 UTC
WYATT FRANK B IISVP, General Counsel & Sec
Exercise / conversionCommon Stock (Right to Buy) · Derivative 125,544 $0.00 Strike: $5.74 $0.00
Disclosure

SEC source: 0001209191-17-026687 · doc4.xml · derivative · entry 5

WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 130,356

Underlying: Common Stock · 125,544 shares

Expires 2021-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017.

Read SEC document
April 10, 2017 Filed Apr 12, 2017 16:28 UTC
WYATT FRANK B IISVP, General Counsel & Sec
SaleCommon Stock 125,544 $40.68 $5,107,619.54
Disclosure

SEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 2

WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,675

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017.

F3 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.46 to $41.07. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
April 10, 2017 Filed Apr 12, 2017 16:28 UTC
WYATT FRANK B IISVP, General Counsel & Sec
Exercise / conversionCommon Stock 125,544 $5.74 $720,622.56
Disclosure

SEC source: 0001209191-17-026687 · doc4.xml · nonDerivative · entry 1

WYATT FRANK B II · CIK 0001210255 · SVP, General Counsel & Sec

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 190,219

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 9, 2017.

F2 · balance_after: As previously reported, includes (a) 7,900 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 6,549 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 2,529 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 11,355 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 2,963 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
April 03, 2017 Filed Apr 4, 2017 16:32 UTC SaleCommon Stock 15,000 $41.63 $624,435.00
Disclosure

SEC source: 0001209191-17-024794 · doc4.xml · nonDerivative · entry 1

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,299,744

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.

F2 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $41.37 to $41.89. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 20, 2017 Filed Mar 20, 2017 17:16 UTC
Edwards Marvin S JrDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 96,200 $0.00 Strike: $5.74 $0.00
Disclosure

SEC source: 0001209191-17-021775 · doc4.xml · derivative · entry 6

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,419,033

Underlying: Common Stock · 96,200 shares

Expires 2021-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016.

Read SEC document
March 20, 2017 Filed Mar 20, 2017 17:16 UTC
Edwards Marvin S JrDirector · President and CEO
SaleCommon Stock 96,200 $40.04 $3,852,242.42
Disclosure

SEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 4

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,034

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016.

F4 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.00 to $40.18. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 20, 2017 Filed Mar 20, 2017 17:16 UTC
Edwards Marvin S JrDirector · President and CEO
Exercise / conversionCommon Stock 96,200 $5.74 $552,188.00
Disclosure

SEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 3

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 373,234

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016.

F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 16, 2017 Filed Mar 20, 2017 17:16 UTC
Edwards Marvin S JrDirector · President and CEO
Exercise / conversionStock Option (Right to Buy) · Derivative 3,800 $0.00 Strike: $5.74 $0.00
Disclosure

SEC source: 0001209191-17-021775 · doc4.xml · derivative · entry 5

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,515,233

Underlying: Common Stock · 3,800 shares

Expires 2021-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016.

Read SEC document
March 16, 2017 Filed Mar 20, 2017 17:16 UTC
Edwards Marvin S JrDirector · President and CEO
SaleCommon Stock 3,800 $40.03 $152,117.42
Disclosure

SEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 2

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,034

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016.

F3 · price: The price shown is the weighted average price of the shares sold in this transaction. The price range for this transaction is $40.01 to $40.11. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 16, 2017 Filed Mar 20, 2017 17:16 UTC
Edwards Marvin S JrDirector · President and CEO
Exercise / conversionCommon Stock 3,800 $5.74 $21,812.00
Disclosure

SEC source: 0001209191-17-021775 · doc4.xml · nonDerivative · entry 1

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 280,834

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2016.

F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018; and (e) 61,452 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020; each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 02, 2017 Filed Mar 3, 2017 21:42 UTC PurchaseCommon Stock 2,000 $39.45 $78,899.80
Disclosure

SEC source: 0001209191-17-017641 · doc4.xml · nonDerivative · entry 1

Yates Timothy T · CIK 0001354697 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,597

F1 · balance_after: As previously reported, includes 4,230 restricted stock units granted on May 6, 2016 pursuant to the issuer's non-employee director compensation plan, which will vest on May 6, 2017, subject to the director's continued membership on the Board of Directors on such date.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:22 UTC
OLSON MARK AEVP and CFO
Exercise / conversionCommon Stock (Right to Buy) · Derivative 15,698 $0.00 Strike: $5.57 $0.00
Disclosure

SEC source: 0001209191-17-017521 · doc4.xml · derivative · entry 6

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 15,698 shares

Expires 2021-02-21

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:22 UTC
OLSON MARK AEVP and CFO
Exercise / conversionStock Option (Right to Buy) · Derivative 14,302 $0.00 Strike: $5.74 $0.00
Disclosure

SEC source: 0001209191-17-017521 · doc4.xml · derivative · entry 5

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,141

Underlying: Common Stock · 14,302 shares

Expires 2021-01-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:22 UTC
OLSON MARK AEVP and CFO
SaleCommon Stock 2,700 $39.46 $106,536.87
Disclosure

SEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 4

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,870

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016.

F4 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.37 to $39.67. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:22 UTC
OLSON MARK AEVP and CFO
SaleCommon Stock 27,300 $39.00 $1,064,577.15
Disclosure

SEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 3

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,570

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016.

F3 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.33. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:22 UTC
OLSON MARK AEVP and CFO
Exercise / conversionCommon Stock 15,698 $5.57 $87,437.86
Disclosure

SEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 2

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,870

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016.

F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:22 UTC
OLSON MARK AEVP and CFO
Exercise / conversionCommon Stock 14,302 $5.74 $82,093.48
Disclosure

SEC source: 0001209191-17-017521 · doc4.xml · nonDerivative · entry 1

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 85,172

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 28, 2016.

F2 · balance_after: As previously reported, includes (a) 13,168 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 4,200 $39.46 $165,739.98
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 12

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Marital Trust

Disclosed balance after: 134,383

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F15 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.34 to $39.63. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 46,193 $39.00 $1,801,619.39
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 11

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Marital Trust

Disclosed balance after: 138,583

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F14 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.32. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 950 $39.40 $37,430.48
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 10

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Family Trust

Disclosed balance after: 18,000

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F13 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.29 to $39.60. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 5,800 $38.97 $226,000.48
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 9

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by Family Trust

Disclosed balance after: 18,950

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F12 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.27 to $39.26. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 900 $39.49 $35,539.02
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 8

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 32,400

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F11 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.38 to $39.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 11,250 $39.01 $438,810.75
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 7

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 33,300

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F10 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.32. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 1,100 $39.46 $43,405.01
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 6

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 32,400

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F9 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.37 to $39.56. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 11,050 $38.99 $430,805.25
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 5

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 33,500

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F8 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.35 to $39.31. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 800 $39.49 $31,593.04
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 4

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 32,400

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F7 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.38 to $39.61. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 11,350 $39.01 $442,727.18
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 3

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By GRAT

Disclosed balance after: 33,200

F5 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 16, 2016.

F6 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.35 to $39.32. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 1,721 $39.43 $67,852.15
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 2

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,314,774

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.

F4 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $39.34 to $39.63. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
March 01, 2017 Filed Mar 3, 2017 16:19 UTC SaleCommon Stock 13,279 $39.00 $517,875.69
Disclosure

SEC source: 0001209191-17-017487 · doc4.xml · nonDerivative · entry 1

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,316,495

F1 · kind: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 5, 2016.

F2 · price: The price shown is the weighted average prices of the shares sold in this transaction. The price range for this transaction is $38.34 to $39.33. The reporting person undertakes to provide, upon request by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price for this transaction.

F3 · balance_after: As previously reported, includes (a) 9,832 restricted stock units that were granted on 02/27/2017 and will vest in three equal installments on 02/27/2018, 02/27/2019, and 02/27/2020; (b) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (c) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (d) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (e) 4,655 performance share units that were earned on 02/23/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 21:43 UTC
Mingle Robyn TSVP of CommScope, Inc.
GrantStock Option (Right to Buy) · Derivative 12,730 $0.00 Strike: $37.97 $0.00
Disclosure

SEC source: 0001209191-17-015923 · doc4.xml · derivative · entry 2

Mingle Robyn T · CIK 0001531828 · SVP of CommScope, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,730

Underlying: Common Stock · 12,730 shares

Expires 2027-02-27

F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 21:43 UTC
Mingle Robyn TSVP of CommScope, Inc.
GrantCommon Stock 5,267 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-015923 · doc4.xml · nonDerivative · entry 1

Mingle Robyn T · CIK 0001531828 · SVP of CommScope, Inc.

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 16,241

F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

F2 · balance_after: As previously reported, includes (a) 3,605 restricted stock units that were granted on 08/01/2016 and will vest ratably on 02/23/2018 and 02/23/2019; and (b) 6,250 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019, each subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:35 UTC
Edwards Marvin S JrDirector · President and CEO
GrantStock Option (Right to Buy) · Derivative 148,525 $0.00 Strike: $37.97 $0.00
Disclosure

SEC source: 0001209191-17-015891 · doc4.xml · derivative · entry 2

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 148,525

Underlying: Common Stock · 148,525 shares

Expires 2027-02-27

F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:35 UTC
Edwards Marvin S JrDirector · President and CEO
GrantCommon Stock 61,452 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-015891 · doc4.xml · nonDerivative · entry 1

Edwards Marvin S Jr · CIK 0001290125 · Director · President and CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 277,034

F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

F2 · balance_after: As previously reported, includes (a) 35,641 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 13,510 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 61,801 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (d) 15,827 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:45 UTC
OLSON MARK AEVP and CFO
GrantStock Option (Right to Buy) · Derivative 31,826 $0.00 Strike: $37.97 $0.00
Disclosure

SEC source: 0001209191-17-015929 · doc4.xml · derivative · entry 2

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,826

Underlying: Common Stock · 31,826 shares

Expires 2027-02-27

F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:45 UTC
OLSON MARK AEVP and CFO
GrantCommon Stock 13,168 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-015929 · doc4.xml · nonDerivative · entry 1

OLSON MARK A · CIK 0001189817 · EVP and CFO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,870

F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

F2 · balance_after: As previously reported, includes (a) 10,692 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 3,613 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 18,540 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (d) 4,233 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:15 UTC GrantStock Option (Right to Buy) · Derivative 23,764 $0.00 Strike: $37.97 $0.00
Disclosure

SEC source: 0001209191-17-015833 · doc4.xml · derivative · entry 7

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,764

Underlying: Common Stock · 23,764 shares

Expires 2027-02-27

F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:15 UTC GrantCommon Stock 9,832 $0.00 $0.00
Disclosure

SEC source: 0001209191-17-015833 · doc4.xml · nonDerivative · entry 1

DRENDEL FRANK M · CIK 0001196634 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 2,329,774

F1 · acquired: Reflects restricted stock units that vest in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

F2 · balance_after: As previously reported, includes (a) 9,980 restricted stock units that were granted on 02/23/2016 and will vest ratably on 02/23/2018 and 02/23/2019; (b) 3,974 restricted stock units that were granted on 02/24/2015 and will vest on 02/24/2018; (c) 17,304 performance share units that were earned on 02/23/2017 and will vest ratably on 02/23/2018 and 02/23/2019; and (d) 4,655 performance share units that were earned on 02/24/2017 and will vest on 02/24/2018, each subject to the reporting person's continued employment with the issuer.

Read SEC document
February 27, 2017 Filed Mar 1, 2017 16:12 UTC GrantStock Option (Right to Buy) · Derivative 36,070 $0.00 Strike: $37.97 $0.00
Disclosure

SEC source: 0001209191-17-015827 · doc4.xml · derivative · entry 2

CRENSHAW RANDALL W · CIK 0001210245 · EVP and COO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,070

Underlying: Common Stock · 36,070 shares

Expires 2027-02-27

F3 · derivative.exercise_date: The option vests in three equal installments on 02/27/2018, 02/27/2019 and 02/27/2020, subject to the reporting person's continued employment with the issuer.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.